Home Tags Stem Cells
Tag: Stem Cells
Peter Diamandis, co-founder of Celularity and Human Longevity, Inc., explains how Silicon Valley can make 100 the new 60.
BlueRock launched in 2016 with $225 million from Bayer and Versant Ventures, with the goal of creating a next-generation regenerative-medicine company.
Here’s the cancer data that led AbbVie to make the 2nd-largest acquisition in the history of venture capital
Stemcentrx wants to target cancer stem cells to treat a form of lung cancer — and we just got more data showing how it works.
Samumed CEO Osman Kibar spoke to CNBC about its valuation and the company's goal to provide "disease-modifying" treatments.
The second-largest acquisition in the history of venture capital happened today — here’s why a pharma giant paid $10 billion for a startup...
Stemcentrx, a former Sillicon Valley unicorn, is developing drugs that go after cancer stem cells. Here's why AbbVie thinks that's a good idea.
A startup that just launched out of stealth a few months ago thinks it’s found a way to treat cancer, and it just got bought for up to $10 billi...
Stemcentrx wants to target cancer stem cells to treat a form of lung cancer.